Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
41
WBA Quote, Financials, Valuation and Earnings
Last price:
$9.56
Seasonality move
:
4.88%
Day range:
$9.28 - $9.62
52-week range:
$8.08 - $27.05
Dividend yield:
10.47%
P/E ratio:
--
P/S ratio:
0.06x
P/B ratio:
0.79x
Volume:
29.3M
Avg. volume:
25.3M
1-year change:
-62.4%
Market cap:
$8.3B
Revenue:
$147.7B
EPS (TTM):
-$6.74
Earnings Data
Next earnings date for WBA
Jan 09
2025
Most recent earnings per share
-$3.48
Missed by $3.84
(Oct 15/2024)
Consensus Estimate
$0.36
(Oct 15/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
WBA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/28/2025 | Q1 | $37.6B | -- | -- | $0.52 | -- |
| 01/09/2025 | Q4 | $37.4B | -- | -- | $0.37 | -- |
| 10/15/2024 | Q3 | $35.6B | $37.5B | -$3.48 | $0.36 | -$3.84 |
| 06/27/2024 | Q2 | $35.9B | $36.4B | $0.40 | $0.71 | -$0.31 |
| 03/28/2024 | Q1 | $35.8B | $37.1B | -$6.85 | $0.82 | -$7.67 |
| 01/04/2024 | Q4 | -- | -- | -$0.08 | $0.62 | -$0.70 |
| 10/12/2023 | Q3 | -- | -- | -$0.21 | $0.69 | -$0.90 |
| 06/27/2023 | Q2 | -- | -- | $0.14 | $1.06 | -$0.92 |
| 03/28/2023 | Q1 | -- | -- | $0.81 | $1.11 | -$0.30 |
| 01/05/2023 | Q4 | -- | -- | -$4.31 | $1.14 | -$5.45 |
| 10/13/2022 | Q3 | -- | -- | -$0.48 | $0.77 | -$1.25 |
| 06/30/2022 | Q2 | -- | -- | $0.33 | $0.92 | -$0.59 |
| 03/31/2022 | Q1 | -- | -- | $1.02 | $1.40 | -$0.38 |
| 01/06/2022 | Q4 | -- | -- | $4.13 | $1.34 | $2.79 |
| 10/14/2021 | Q3 | -- | -- | $0.72 | $1.02 | -$0.30 |
| 07/01/2021 | Q2 | -- | -- | $1.38 | $1.15 | $0.23 |
| 03/31/2021 | Q1 | -- | -- | $1.19 | $1.11 | $0.08 |
| 01/07/2021 | Q4 | -- | -- | -$0.36 | $1.04 | -$1.40 |
| 10/15/2020 | Q3 | -- | -- | $0.43 | $0.96 | -$0.53 |
| 07/09/2020 | Q2 | -- | -- | -$1.95 | $1.20 | -$3.15 |
| 04/02/2020 | Q1 | -- | -- | $1.07 | $1.46 | -$0.39 |
| 01/08/2020 | Q4 | -- | -- | $0.95 | $1.41 | -$0.46 |
| 10/28/2019 | Q3 | -- | -- | $0.75 | $1.41 | -$0.66 |
| 06/27/2019 | Q2 | -- | -- | $1.13 | $1.43 | -$0.30 |
| 04/02/2019 | Q1 | -- | -- | $1.24 | $1.71 | -$0.47 |
| 12/20/2018 | Q4 | -- | -- | $1.18 | $1.44 | -$0.26 |
| 10/11/2018 | Q3 | -- | -- | $1.55 | $1.45 | $0.10 |
| 06/28/2018 | Q2 | -- | -- | $1.35 | -- | -- |
| 03/28/2018 | Q1 | -- | -- | $1.36 | -- | -- |
| 01/04/2018 | Q4 | -- | -- | $0.81 | -- | -- |
| 10/25/2017 | Q3 | -- | -- | $0.76 | -- | -- |
| 06/29/2017 | Q2 | -- | -- | $1.07 | -- | -- |
| 04/05/2017 | Q1 | -- | -- | $0.98 | -- | -- |
| 01/05/2017 | Q4 | -- | -- | $0.97 | -- | -- |
| 10/20/2016 | Q3 | -- | -- | $0.95 | -- | -- |
| 07/06/2016 | Q2 | -- | -- | $1.01 | -- | -- |
| 04/05/2016 | Q1 | -- | -- | $0.85 | -- | -- |
| 01/07/2016 | Q4 | -- | -- | $1.01 | -- | -- |
| 10/28/2015 | Q3 | -- | -- | $0.02 | -- | -- |
| 07/09/2015 | Q2 | -- | -- | $1.18 | -- | -- |
| 04/09/2015 | Q1 | -- | -- | $1.93 | -- | -- |
Walgreens Boots Alliance Earnings Questions
-
How Much did Walgreens Boots Alliance Generate in Revenue Last Quarter?
Walgreens Boots Alliance reported $37.5B worth of top line sales in its most recent quarter.
-
Did Walgreens Boots Alliance Beat Earnings Last Quarter?
Walgreens Boots Alliance announced earnings per share of -$3.48 which represents a miss of analyst forecast a $0.36 per share.
-
Is Walgreens Boots Alliance Profitable?
Walgreens Boots Alliance reported $6.5B that represents $7.47 per share over the last quarter.
-
What is the Analyst Consensus for Walgreens Boots Alliance EPS Next Year?
Walgreens Boots Alliance's earnings are forecast to decrease from -$10.01 per share to $2.85 per share next year representing a decrease of -20.23%.
-
When is Walgreens Boots Alliance's Earnings Date?
Walgreens Boots Alliance's next earnings date is January 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
